Home Menu ↓
Clicking on our sponsor links helps insure continued free access to this website.
Please support our efforts by visiting our sponsors:

 

MEDTRONIC INC. v. BOSTON SCIENTIFIC CORP.

Docket No.: 12-1128
Certiorari Granted: May 20 2013
Argued: November 5, 2013

Topics:

Article I, patent, res judicata

PartyNames: Medtronic Inc. v. Boston Scientific Corporation, et al.
Petitioner: Medtronic Inc.
Respondent: Boston Scientific Corporation, et al.

Court Below: United States Court of Appeals for the Federal Circuit
Citation: 695 F.3d 1266
Supreme Court Docket

Medtronic Inc.
v.
Boston Scientific Corporation, et al.
Question Presented:

In Medlmmune, Inc. v. Genentech, Inc., 549 U.S. 118, 137 (2007), this Court ruled that a patent licensee that believes that its products do not infringe the patent and accordingly are not subject to royalty payments is "not required ... to break or terminate its ... license agreement before seeking a declaratory judgment in federal court that the underlying patent is ... not infringed." The question presented is whether, in such a declaratory judgment action brought by a licensee under Medlmmune, the licensee has the burden to prove that its products do not infringe the patent, or whether (as is the case in all other patent litigation, including other declaratory judgment actions), the patentee must prove infringement.

MEDTRONIC INC. v. BOSTON SCIENTIFIC CORP.
ORAL ARGUMENT

November 5, 2013

Listen to Oral Argument in MEDTRONIC INC. v. BOSTON SCIENTIFIC CORP.
Database Connection failed: SQLSTATE[HY000] [1045] Access denied for user 'restauz8_sophi'@'localhost' (using password: YES)